Newer approaches in treating chronic myelogenous leukemia

Leuk Lymphoma. 1993:11 Suppl 1:293-6. doi: 10.3109/10428199309047901.

Abstract

We evaluated the recovery of human hematopoietic progenitors in long-term bone marrow culture (LTBMC) initiated in tissue culture (TC) flasks to that in "Lifecell" bags, which are gas-permeable plastic bags in which feeder-layer cells cannot adhere. Cells were incubated in presence of IL-1 and IL-3. Our experiments reveal sustained hematopoietic stem cell growth in the absence of a feeder layer in plastic gas-permeable bags. Evaluations of marrow from patients with chronic myelogenous leukemia suggests enrichment of normal hematopoietic precursors. Combining effective drugs to decrease Ph(+) clone prior to bone marrow harvest and use of cultured bone marrow may provide a useful method for treating patients with chronic myelogenous leukemia.

MeSH terms

  • Bone Marrow Cells*
  • Bone Marrow Transplantation / methods*
  • Cell Adhesion
  • Cell Count
  • Cell Division
  • Cells, Cultured
  • Colony-Forming Units Assay
  • Colony-Stimulating Factors / pharmacology
  • Culture Techniques / instrumentation*
  • Feasibility Studies
  • Hematopoietic Stem Cells / cytology*
  • Hematopoietic Stem Cells / drug effects
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / surgery*
  • Plastics
  • Recombinant Proteins / pharmacology

Substances

  • Colony-Stimulating Factors
  • Plastics
  • Recombinant Proteins